General

Showing 1617–1632 of 2318 results

Article: P19 EVALUATION OF AN AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY
€3.03 Add to cart
Article: P19 Receptor tyrosine kinase AXL: a potential new target in multiple myeloma
€3.03 Add to cart
Article: P19 Vanishing bile duct syndrome associated with diffuse large B-cell lymphoma
€3.03 Add to cart
Article: P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients
€3.03 Add to cart
Article: P2.01 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
€3.03 Add to cart
Article: P2.01 Functional evaluation of T cells generated from WT1-TCR transduced human hematopoietic stem cells using the OP9-DL1 coculture system
€3.03 Add to cart
Article: P2.02 Belgian consensus on the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria
€3.03 Add to cart
Article: P2.02 The value of SOX11 overexpression in the differential diagnosis of mantle cell lymphoma
€3.03 Add to cart
Article: P2.03 Belgian Stop IMatinib trial
€3.03 Add to cart
Article: P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96
€3.03 Add to cart
Article: P2.03 Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation
€3.03 Add to cart
Article: P2.04 Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates
€3.03 Add to cart
Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells
€3.03 Add to cart
Article: P2.04 Role of microvesicles derived from leukemic blast in DIC and thrombosis.
€3.03 Add to cart
Article: P2.05 Global HDAC enzymatic activity is a strong marker of poor prognosis in Chronic Lymphocytic Leukemia
€3.03 Add to cart
Article: P2.05 Intravenous immunoglobulins as a preventive treatment of maternofoetal platelet alloimmunisation
€3.03 Add to cart

Article: P19 EVALUATION OF AN AUTOMATED LIGHT TRANSMISSION AGGREGOMETRY

Article: P19 Receptor tyrosine kinase AXL: a potential new target in multiple myeloma

Article: P19 Vanishing bile duct syndrome associated with diffuse large B-cell lymphoma

Article: P2.01 Downregulation of cellular microRNA-150 is a new prognostic factor associated with a poor prognosis in Chronic Lymphocytic Leukemia patients

Article: P2.01 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96

Article: P2.01 Functional evaluation of T cells generated from WT1-TCR transduced human hematopoietic stem cells using the OP9-DL1 coculture system

Article: P2.02 Belgian consensus on the diagnosis and management of Paroxysmal Nocturnal Hemoglobinuria

Article: P2.02 The value of SOX11 overexpression in the differential diagnosis of mantle cell lymphoma

Article: P2.03 Belgian Stop IMatinib trial

Article: P2.03 Evaluation of the Red Blood Cell Advanced Software Application on the CellaVision DM96

Article: P2.03 Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation

Article: P2.04 Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates

Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells

Article: P2.04 Role of microvesicles derived from leukemic blast in DIC and thrombosis.

Article: P2.05 Global HDAC enzymatic activity is a strong marker of poor prognosis in Chronic Lymphocytic Leukemia

Article: P2.05 Intravenous immunoglobulins as a preventive treatment of maternofoetal platelet alloimmunisation